OPTIMI HEALTH CORP. (8BN) - Net Assets
Based on the latest financial reports, OPTIMI HEALTH CORP. (8BN) has net assets worth €5.02 Million EUR (≈ $5.87 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€14.24 Million ≈ $16.64 Million USD) and total liabilities (€9.22 Million ≈ $10.78 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how tangible is OPTIMI HEALTH CORP.'s equity to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €5.02 Million |
| % of Total Assets | 35.24% |
| Annual Growth Rate | -25.7% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 5.83 |
OPTIMI HEALTH CORP. - Net Assets Trend (2022–2025)
This chart illustrates how OPTIMI HEALTH CORP.'s net assets have evolved over time, based on quarterly financial data. See OPTIMI HEALTH CORP. (8BN) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for OPTIMI HEALTH CORP. (2022–2025)
The table below shows the annual net assets of OPTIMI HEALTH CORP. from 2022 to 2025. For live valuation and market cap data, see OPTIMI HEALTH CORP. stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | €6.57 Million ≈ $7.68 Million |
-31.38% |
| 2024-09-30 | €9.58 Million ≈ $11.20 Million |
-27.52% |
| 2023-09-30 | €13.21 Million ≈ $15.44 Million |
-17.54% |
| 2022-09-30 | €16.02 Million ≈ $18.73 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to OPTIMI HEALTH CORP.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1381460200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €33.81 Million | 514.60% |
| Total Equity | €6.57 Million | 100.00% |
OPTIMI HEALTH CORP. Competitors by Market Cap
The table below lists competitors of OPTIMI HEALTH CORP. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ZOONO Group Ltd
AU:ZNO
|
$18.39 Million |
|
Medicus Pharma Ltd. Common Stock
NASDAQ:MDCX
|
$18.41 Million |
|
Vereinigte Filzfabriken AG
MU:VFF
|
$18.41 Million |
|
African Media Entertainment
JSE:AME
|
$18.41 Million |
|
M4B SA ZY 8
F:24D
|
$18.39 Million |
|
UMS-Neiken Group Bhd
KLSE:7227
|
$18.38 Million |
|
Austem Company Ltd
KQ:031510
|
$18.38 Million |
|
Northeast Electric Development Company Limited
F:NE4H
|
$18.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in OPTIMI HEALTH CORP.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 9,575,712 to 6,570,661, a change of -3,005,051 (-31.4%).
- Net loss of 3,712,031 reduced equity.
- New share issuances of 395,000 increased equity.
- Other factors increased equity by 311,980.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-3.71 Million | -56.49% |
| Share Issuances | €395.00K | +6.01% |
| Other Changes | €311.98K | +4.75% |
| Total Change | €- | -31.38% |
Book Value vs Market Value Analysis
This analysis compares OPTIMI HEALTH CORP.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 49.34x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 16.95x to 49.34x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-09-30 | €0.20 | €3.36 | x |
| 2023-09-30 | €0.15 | €3.36 | x |
| 2024-09-30 | €0.10 | €3.36 | x |
| 2025-09-30 | €0.07 | €3.36 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently OPTIMI HEALTH CORP. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -56.49%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -870.75%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 2.32x
- Recent ROE (-56.49%) is below the historical average (-51.18%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -45.89% | -9106.91% | 0.00x | 1.05x | €-8.95 Million |
| 2023 | -39.32% | -2868.54% | 0.01x | 1.25x | €-6.52 Million |
| 2024 | -63.03% | -1548.25% | 0.03x | 1.52x | €-6.99 Million |
| 2025 | -56.49% | -870.75% | 0.03x | 2.32x | €-4.37 Million |
Industry Comparison
This section compares OPTIMI HEALTH CORP.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $5,659,440,547
- Average return on equity (ROE) among peers: -44.43%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| OPTIMI HEALTH CORP. (8BN) | €5.02 Million | -45.89% | 1.84x | $18.39 Million |
| SHANG.FOS.PHARM.GR.H YC 1 (08HH) | $48.38 Billion | 9.77% | 0.93x | $1.13 Billion |
| PEPTONIC MEDICAL (28L) | $48.55 Million | -123.64% | 0.45x | $4.14 Million |
| Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) | $7.85 Billion | 28.40% | 0.37x | $692.11 Million |
| WEST ISLAND BRANDS INC. (39N0) | $3.27 Million | -157.21% | 0.88x | $1.34 Million |
| AYURCANN HOLDINGS CORP. (3ZQ0) | $2.69 Million | -197.11% | 3.73x | $97.35K |
| CERENO SCIENTIFIC AB B (4A1) | $170.06 Million | -9.56% | 0.06x | $157.72 Million |
| MAPLE LEAF GREEN WORLD (4HV0) | $-8.83 Million | 0.00% | 0.00x | $504.30K |
| LORDS CO. WORLDW. HOLD. (4XM) | $-815.79K | 0.00% | 0.00x | $134.78K |
| RED LIGHT HOLLAND CORP. (4YX) | $26.34 Million | -20.49% | 0.14x | $7.31 Million |
| EQL PHARMA AB (7JK) | $123.63 Million | 25.52% | 0.92x | $73.36 Million |
About OPTIMI HEALTH CORP.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and… Read more